Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: May 26, 2022. (Total: 3849 publications since 2011)
   dataset
Filtered By:
Records 1-16 (of 16 Records)
Query Trace: all>>Tom T Shimabukuro[CDC Author]
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
Matthew E Oster, David K Shay, John R Su, Julianne Gee, C Buddy Creech, Karen R Broder, Kathryn Edwards, Jonathan H Soslow, Jeffrey M Dendy, Elizabeth Schlaudecker, Sean M Lang, Elizabeth D Barnett, Frederick L Ruberg, Michael J Smith, M Jay Campbell, Renato D Lopes, Laurence S Sperling, Jane A Baumblatt, Deborah L Thompson, Paige L Marquez, Penelope Strid, Jared Woo, River Pugsley, Sarah Reagan-Steiner, Frank Destefano, and Tom T Shimabukuro
JAMA 2022 327(4) 331-340
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
Johanna Chapin-Bardales, Tanya Myers, Julianne Gee, David K Shay, Paige Marquez, James Baggs, Bicheng Zhang, Charles Licata, and Tom T Shimabukuro
Vaccine 2021
Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
Nicola P Klein, Ned Lewis, Kristin Goddard, Bruce Fireman, Ousseny Zerbo, Kayla E Hanson, James G Donahue, Elyse O Kharbanda, Allison Naleway, Jennifer Clark Nelson, Stan Xu, W Katherine Yih, Jason M Glanz, Joshua T B Williams, Simon J Hambidge, Bruno J Lewin, Tom T Shimabukuro, Frank Destefano, and Eric S Weintraub
JAMA 2021 9
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.
David K Shay, Tom T Shimabukuro, and Frank Destefano
JAMA cardiology 2021 6
Safety of the 9-Valent Human Papillomavirus Vaccine.
Tom T Shimabukuro, John R Su, Paige L Marquez, Adamma Mba-Jonas, Jorge E Arana, and Maria V Cano
Pediatrics 2019 144(6)
Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017.
Tiffany A Suragh, Paige Lewis, Jorge Arana, Adamma Mba-Jonas, Rongxia Li, Brock Stewart, Tom T Shimabukuro, and Maria Cano
British journal of clinical pharmacology 2018 84(12) 2928-2932
Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
Jorge E Arana, Theresa Harrington, Maria Cano, Paige Lewis, Adamma Mba-Jonas, Li Rongxia, Brock Stewart, Lauri E Markowitz, and Tom T Shimabukuro
Vaccine 2018 36(13) 1781-1788
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
Elaine R Miller, Paige Lewis, Tom T Shimabukuro, John Su, Pedro Moro, Emily Jane Woo, Christopher Jankosky, and Maria Cano
Human vaccines & immunotherapeutics 2018 14(8) 1963-1969
Safety of Second-Dose Single-Antigen Varicella Vaccine.
John R Su, Zanie Leroy, Paige W Lewis, Penina Haber, Mona Marin, Jessica Leung, Emily Jane Woo, and Tom T Shimabukuro
Pediatrics 2017 Mar 139(3)
Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.
Jorge Arana, Adamma Mba-Jonas, Christopher Jankosky, Paige Lewis, Pedro L Moro, Tom T Shimabukuro, and Maria Cano
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2017 Nov 61(5) 577-582
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013.
Elaine R Miller, Pedro L Moro, Maria Cano, Paige Lewis, Marthe Bryant-Genevier, and Tom T Shimabukuro
Vaccine 2016 34(25) 2841-6
Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013.
Pedro L Moro, Christopher Jankosky, David Menschik, Paige Lewis, Jonathan Duffy, Brock Stewart, and Tom T Shimabukuro
The Journal of pediatrics 2015 Apr 166(4) 992-7
Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014.
Penina Haber, Pedro L Moro, Maria Cano, Paige Lewis, Brock Stewart, and Tom T Shimabukuro
Vaccine 2015 Apr 33(16) 1987-92
Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.
Lakshmi Sukumaran, Michael M McNeil, Pedro L Moro, Paige W Lewis, Scott K Winiecki, and Tom T Shimabukuro
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 May 60(10) e58-65
Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax(®)) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015.
Pedro L Moro, Scott Winiecki, Paige Lewis, Tom T Shimabukuro, and Maria Cano
Vaccine 2015 Nov 33(48) 6684-8
Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.
Penina Haber, Pedro L Moro, Michael M McNeil, Paige Lewis, Emily Jane Woo, Hayley Hughes, and Tom T Shimabukuro
Vaccine 2014 Nov 32(48) 6499-504
TOP